Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations

<table>Circulating CD4+ T cells in cutaneous melanoma patients. </table>

BioMed Research International

Figure 3: Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations 